Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1975 Apr;28(4):289–297. doi: 10.1136/jcp.28.4.289

Cell receptor studies on seven cases of diffuse histiocytic malignant lymphoma (reticulum cell sarcoma).

J A Habeshaw, A E Stuart
PMCID: PMC475693  PMID: 1092721

Abstract

Expression of B and T lymphocyte receptors has been studied in seven cases of reticulum cell sarcoma. In one case, surface receptors and tests of phagocytic function demonstrated the histiocytic origin of the neoplastic cells. In four cases, tumour cells expressed both B and T lymphocyte markers (two cases) or showed a normal pattern of expression of B and T lymphocyte markers. In the other two cases, lymphocyte receptors were not detected, and there was no evidence of phagocytic function: this class of receptor-silent tumours is of uncertain pathogenesis. The significance of these observations is discussed.

Full text

PDF
295

Images in this article

291Image
on p.291
292Image
on p.292
293Image
on p.293
294Image
on p.294
294Image
on p.294
294Image
on p.294
295Image
on p.295
295Image
on p.295

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown G., Greaves M. F. Enumeration of absolute numbers of T and B lymphocytes in human blood. Scand J Immunol. 1974;3(2):161–172. doi: 10.1111/j.1365-3083.1974.tb01244.x. [DOI] [PubMed] [Google Scholar]
  2. Dewar A. E., Habeshaw J. A., Young G. A., Stuart A. E., Parker A. C., Wilson D. C. Letter: Mixed receptors. Lancet. 1974 Jul 27;2(7874):216–216. doi: 10.1016/s0140-6736(74)91511-6. [DOI] [PubMed] [Google Scholar]
  3. Dickler H. B., Adkinson N. F., Jr, Terry W. D. Evidence for individual human peripheral blood lymphocytes bearing both B and T cell markers. Nature. 1974 Jan 25;247(5438):213–215. doi: 10.1038/247213a0. [DOI] [PubMed] [Google Scholar]
  4. Edelson R. L., Kirkpatrick C. H., Shevach E. M., Schein P. S., Smith R. W., Green I., Lutzner M. Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studies. Ann Intern Med. 1974 Jun;80(6):685–692. doi: 10.7326/0003-4819-80-6-685. [DOI] [PubMed] [Google Scholar]
  5. Fröland S. S. Binding of sheep erythrocytes to human lymphocytes. A probable marker of T lymphocytes. Scand J Immunol. 1972;1(3):269–280. doi: 10.1111/j.1365-3083.1972.tb01818.x. [DOI] [PubMed] [Google Scholar]
  6. Fröland S., Natvig J. B., Berdal P. Surface-bound immunoglobulin as a marker of B lymphocytes in man. Nat New Biol. 1971 Dec 22;234(51):251–252. doi: 10.1038/newbio234251a0. [DOI] [PubMed] [Google Scholar]
  7. GALL E. A. The cytological identity and interrelation of mesenchymal cells of lymphoid tissue. Ann N Y Acad Sci. 1958 Sep 5;73(1):120–130. doi: 10.1111/j.1749-6632.1959.tb40796.x. [DOI] [PubMed] [Google Scholar]
  8. Jaffe E. S., Shevach E. M., Frank M. M., Berard C. W., Green I. Nodular lymphoma--evidence for origin from follicular B lymphocytes. N Engl J Med. 1974 Apr 11;290(15):813–819. doi: 10.1056/NEJM197404112901501. [DOI] [PubMed] [Google Scholar]
  9. Mellstedt H., Pettersson D. Lymphocyte subpopulations in chronic lymphocytic leukemia. Characterization by cell surface markers, cytotoxic activity, and mitogenic stimulation. Scand J Immunol. 1974;3(3):303–310. doi: 10.1111/j.1365-3083.1974.tb01261.x. [DOI] [PubMed] [Google Scholar]
  10. Piessens W. F., Schur P. H., Moloney W. C., Churchill W. H. Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases. N Engl J Med. 1973 Jan 25;288(4):176–180. doi: 10.1056/NEJM197301252880403. [DOI] [PubMed] [Google Scholar]
  11. Pincus S., Bianco C., Nussenzweig V. Increased proportion of complement-receptor lymphocytes in the peripheral blood of patients with chronic lymphocytic leukemia. Blood. 1972 Sep;40(3):303–310. [PubMed] [Google Scholar]
  12. Sandilands G. P., Gray K., Cooney A., Browning J. D., Grant R. M., Anderson J. R., Dagg J. H., Lucie N. Lymphocytes with T and B cell properties in a lymphoproliferative disorder. Lancet. 1974 May 11;1(7863):903–904. doi: 10.1016/s0140-6736(74)90350-x. [DOI] [PubMed] [Google Scholar]
  13. Shevach E. M., Jaffe E. S., Green I. Receptors for complement and immunoglobulin on human and animal lymphoid cells. Transplant Rev. 1973;16:3–28. doi: 10.1111/j.1600-065x.1973.tb00115.x. [DOI] [PubMed] [Google Scholar]
  14. Silberman S., Schrek R. Surface immunoglobulins of lymphocytes in chronic lymphocytic leukemia and disseminated lymphosarcoma. Exp Mol Pathol. 1974 Feb;20(1):33–39. doi: 10.1016/0014-4800(74)90041-0. [DOI] [PubMed] [Google Scholar]
  15. Smith J. L., Clein G. P., Barker C. R., Collins R. D. Characterisation of malignant mediastinal lymphoid neoplasm (Sternberg sarcoma) as thymic in origin. Lancet. 1973 Jan 13;1(7794):74–77. doi: 10.1016/s0140-6736(73)90469-8. [DOI] [PubMed] [Google Scholar]
  16. Wybran J., Fudenberg H. Editorial: How clinically useful is T and B cell quantitation? Ann Intern Med. 1974 Jun;80(6):765–767. doi: 10.7326/0003-4819-80-6-765. [DOI] [PubMed] [Google Scholar]
  17. Yoshida T. O., Andersson B. Evidence for a receptor recognizing antigen complexed immunoglobulin on the surface of activated mouse thymus lymphocytes. Scand J Immunol. 1972;1(4):401–408. doi: 10.1111/j.1365-3083.1972.tb03306.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES